Similar articles

• The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

  Slocum NK, Grossman PM, Moscucci M, Smith DE, Aronow HD, Dixon SR, Share D, Gurm HS. Slocum NK, et al. Am Heart J. 2012 May;163(5):829-34. doi: 10.1016/j.ahj.2012.02.011. Am Heart J. 2012. PMID: 22607861
• Does the current definition of contrast-induced acute kidney injury reflect a true clinical entity?

  Sinert R, Brandler E, Subramanian RA, Miller AC. Sinert R, et al. Acad Emerg Med. 2012 Nov;19(11):1261-7. doi: 10.1111/acem.12011. Acad Emerg Med. 2012. PMID: 23167857
• Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?

  Katzberg RW, Newhouse JH. Katzberg RW, et al. Radiology. 2010 Jul;256(1):21-8. doi: 10.1148/radiol.10092000. Radiology. 2010. PMID: 20574082 No abstract available.
• Subclinical acute kidney injury (AKI) due to iodine-based contrast media.

  Ronco C, Stacul F, McCullough PA. Ronco C, et al. Eur Radiol. 2013 Feb;23(2):319-23. doi: 10.1007/s00330-012-2607-y. Epub 2012 Aug 16. Eur Radiol. 2013. PMID: 22895617 Review.
• The role of dialysis in contrast-induced nephropathy: doubts and certainties.

  Guastoni C, De Servi S, D'Amico M. Guastoni C, et al. J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):549-57. doi: 10.2459/01.JCM.0000281709.43681.a5. J Cardiovasc Med (Hagerstown). 2007. PMID: 17667024 Review.